3os9: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
 
(8 intermediate revisions by the same user not shown)
Line 1: Line 1:
[[Image:3os9.png|left|200px]]


{{STRUCTURE_3os9|  PDB=3os9  |  SCENE= }}
==Estrogen Receptor==
 
<StructureSection load='3os9' size='340' side='right'caption='[[3os9]], [[Resolution|resolution]] 2.30&Aring;' scene=''>
===Estrogen Receptor===
== Structural highlights ==
 
<table><tr><td colspan='2'>[[3os9]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3OS9 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3OS9 FirstGlance]. <br>
{{ABSTRACT_PUBMED_20924370}}
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.303&#8491;</td></tr>
 
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=KN1:4-[1-ALLYL-7-(TRIFLUOROMETHYL)-1H-INDAZOL-3-YL]BENZENE-1,3-DIOL'>KN1</scene></td></tr>
==About this Structure==
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3os9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3os9 OCA], [https://pdbe.org/3os9 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3os9 RCSB], [https://www.ebi.ac.uk/pdbsum/3os9 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3os9 ProSAT]</span></td></tr>
[[3os9]] is a 4 chain structure of [[Estrogen receptor]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3OS9 OCA].  
</table>
== Function ==
[https://www.uniprot.org/uniprot/ESR1_HUMAN ESR1_HUMAN] Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Ligand-dependent nuclear transactivation involves either direct homodimer binding to a palindromic estrogen response element (ERE) sequence or association with other DNA-binding transcription factors, such as AP-1/c-Jun, c-Fos, ATF-2, Sp1 and Sp3, to mediate ERE-independent signaling. Ligand binding induces a conformational change allowing subsequent or combinatorial association with multiprotein coactivator complexes through LXXLL motifs of their respective components. Mutual transrepression occurs between the estrogen receptor (ER) and NF-kappa-B in a cell-type specific manner. Decreases NF-kappa-B DNA-binding activity and inhibits NF-kappa-B-mediated transcription from the IL6 promoter and displace RELA/p65 and associated coregulators from the promoter. Recruited to the NF-kappa-B response element of the CCL2 and IL8 promoters and can displace CREBBP. Present with NF-kappa-B components RELA/p65 and NFKB1/p50 on ERE sequences. Can also act synergistically with NF-kappa-B to activate transcription involving respective recruitment adjacent response elements; the function involves CREBBP. Can activate the transcriptional activity of TFF1. Also mediates membrane-initiated estrogen signaling involving various kinase cascades. Isoform 3 is involved in activation of NOS3 and endothelial nitric oxide production. Isoforms lacking one or several functional domains are thought to modulate transcriptional activity by competitive ligand or DNA binding and/or heterodimerization with the full length receptor. Isoform 3 can bind to ERE and inhibit isoform 1.<ref>PMID:7651415</ref> <ref>PMID:10970861</ref> <ref>PMID:9328340</ref> <ref>PMID:10681512</ref> <ref>PMID:10816575</ref> <ref>PMID:11477071</ref> <ref>PMID:11682626</ref> <ref>PMID:15078875</ref> <ref>PMID:16043358</ref> <ref>PMID:15891768</ref> <ref>PMID:16684779</ref> <ref>PMID:18247370</ref> <ref>PMID:17932106</ref> <ref>PMID:19350539</ref> <ref>PMID:20705611</ref> <ref>PMID:21937726</ref> <ref>PMID:21330404</ref> <ref>PMID:22083956</ref>


==See Also==
==See Also==
*[[Estrogen receptor|Estrogen receptor]]
*[[Estrogen receptor 3D structures|Estrogen receptor 3D structures]]
 
== References ==
==Reference==
<references/>
<ref group="xtra">PMID:020924370</ref><references group="xtra"/>
__TOC__
</StructureSection>
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Adams, P D.]]
[[Category: Large Structures]]
[[Category: Afonine, P V.]]
[[Category: Adams PD]]
[[Category: Bruning, J.]]
[[Category: Afonine PV]]
[[Category: Gil, G.]]
[[Category: Bruning J]]
[[Category: Katzenellenbogen, J A.]]
[[Category: Gil G]]
[[Category: Nettles, K W.]]
[[Category: Katzenellenbogen JA]]
[[Category: Nowak, J.]]
[[Category: Nettles KW]]
[[Category: Pace, M C.]]
[[Category: Nowak J]]
[[Category: Parent, A A.]]
[[Category: Pace MC]]
[[Category: Smith, C L.]]
[[Category: Parent AA]]
[[Category: Zhao, M.]]
[[Category: Smith CL]]
[[Category: Estrogen receptor complex]]
[[Category: Zhao M]]
[[Category: Signaling protein]]

Latest revision as of 10:36, 21 February 2024

Estrogen Receptor

3os9, resolution 2.30Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA